Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis

This publication has 39 references indexed in Scilit:

• Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
  Cancer, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Topoisomerase II-α expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma
  Journal of Clinical Pathology, 2006
• Characterization of human NSCLC cell line with innate etoposide‐resistance mediated by cytoplasmic localization of topoisomerase II alpha
  Cancer Science, 2005
• The cytoplasmic trafficking of DNA topoisomerase IIα correlates with etoposide resistance in human myeloma cells
  Experimental Cell Research, 2004
• Nuclear expression of Y‐box‐binding protein‐1 correlates with P‐glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma
  The Journal of Pathology, 2003
• Topoisomerase IIα and other drug resistance markers in advanced non-small cell lung cancer
  Lung Cancer, 2001
• Topoisomerase II??: Prognostic Predictor and Cell Cycle Marker in Surface Epithelial Neoplasms of the Ovary and Peritoneum
  International Journal of Gynecological Pathology, 2000
• Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables
  Laboratory Investigation, 2000
• Cell density‐dependent VP‐16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIα from the nucleus to the cytoplasm
  British Journal of Haematology, 2000